NCT07826494

Brief Summary

This research study will examine the acute effects of non-invasive spinal stimulation on spasticity and walking in individuals with cerebral palsy. The hypothesis is that walking with spinal stimulation will lead to greater reductions in spasticity than walking without spinal stimulation. Additionally, it is hypothesized that the average step length and Gait Deviation Index will be higher while walking with spinal stimulation compared to walking without spinal stimulation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
26mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Aug 2026Dec 2028

Study Start

First participant enrolled

August 13, 2026

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

August 25, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

1.8 years

First QC Date

August 25, 2026

Last Update Submit

September 14, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Modified Tardieu Scale of Spasticity

    Change in quality of muscle reaction of the gastrocnemius assessed by the score on the Tardieu assessment. Lower score indicates less spasticity.

    End of treadmill walking during visit, anticipated average 20 minutes, relative to baseline at start of visit.

Secondary Outcomes (2)

  • Step Length

    End of treadmill walking during visit, anticipated average 20 minutes, relative to baseline at start of visit.

  • Gait Deviation Index (GDI)

    Last 5 minutes of treadmill walking during visit relative to baseline at start of walking.

Study Arms (2)

Spinal Stimulation First (AB Arm)

EXPERIMENTAL

Participants randomized into this arm will complete two visits. The first visit will use spinal stimulation while walking on a treadmill, and the second visit will be treadmill walking without stimulation.

Device: Spinal StimulationOther: Treadmill Walking

No Spinal Stimulation First (BA Arm)

EXPERIMENTAL

Participants randomized into this arm will complete two visits. The first visit will involve walking on a treadmill without stimulation, while the second visit will be treadmill walking with stimulation.

Device: Spinal StimulationOther: Treadmill Walking

Interventions

A stimulator will be used non-invasively stimulate the spine at the neck and/or lower back (cervical and/or lumbar).

Also known as: SpineX, xStep
No Spinal Stimulation First (BA Arm)Spinal Stimulation First (AB Arm)

Participant will walk on a treadmill.

No Spinal Stimulation First (BA Arm)Spinal Stimulation First (AB Arm)

Eligibility Criteria

Age4 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals who:
  • have a diagnosis of spastic cerebral palsy or high likelihood of CP diagnosis
  • are 4-65 years of age
  • have spasticity in lower-extremity muscles
  • are at a functional Gross Motor Function Classification System (GMFCS) Level I-III
  • can walk for at least 10 minutes with/without support
  • can understand and follow simple directions
  • have a stable medical condition, as reported by the caregiver/parent

You may not qualify if:

  • Individuals who:
  • who have had lower-extremity surgery or injury in the prior 12 months
  • have had botulinum toxin injections in the prior 3 months
  • have had selective dorsal rhizotomy (SDR) in the past
  • have uncontrolled seizures
  • have significant cardiovascular or musculoskeletal disease that would prevent full participation
  • are dependent on ventilation support
  • have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)
  • have established osteoporosis and taking medication for osteoporosis treatment.
  • have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)
  • have active cancer
  • have received stem cell injections into the spinal cord

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98195, United States

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Spinal Cord Stimulation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Katherine Steele, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR
  • Heather Feldner, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katherine Steele, PhD

CONTACT

Katie Landwehr, MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participant and caregiver is not informed about the order of visits with and without stimulation and are told that they "may or may not feel stimulation" at each visit. During the visit without stimulation, the electrodes are still placed and connected to the device without delivering stimulation.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 25, 2026

First Posted

September 17, 2026

Study Start

August 13, 2026

Primary Completion (Estimated)

June 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

September 17, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified IPD of each outcome measure will be made available on the NICHD Data and Specimen Hub (DASH) and reported in aggregate on clinicaltrials.gov.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
IPD will be made available 6 months following publication of study results.
Access Criteria
Direct access with registration on NIH repository.

Locations